$DTIL insider trading
Over the last 12 months, Precision Biosciences insiders reported 5 buys totaling $54K and 11 sales totaling $466K across SEC Form 4 filings. 69% of those filings were made under pre-arranged 10b5-1 trading plans.
- Bought · 12m
- $54K 5 events
- Sold · 12m
- $466K 11 events
- Events · 12m
- 16 Form 4 filings, grouped
- Insiders · 12m
- 7 distinct reporters
- 10b5-1 share
- 69% of events, not dollars
All insider trades
Scroll the table sideways for price, value and marks.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Feb 18, 2026 | Amoroso MichaelPresident and CEO · O·D | ▼ Sale | 20,559 | $3.84 | $79K | -7.8% | plan |
| Feb 18, 2026 | Kelly John AlexanderChief Financial Officer · O | ▼ Sale | 8,149 | $3.84 | $31K | -6.1% | plan |
| Feb 18, 2026 | Scimeca DarioGeneral Counsel and Secretary · O | ▼ Sale | 4,925 | $3.84 | $19K | -8% | plan |
| Feb 18, 2026 | SMITH J. JEFFERSONChief Research Officer · O | ▼ Sale | 4,925 | $3.84 | $19K | -3.9% | plan |
| Jan 22, 2026 | Amoroso MichaelPresident and CEO · O·D | ▼ Sale | 34,799 | $4.17 | $145K | -15.1% | plan |
| Jan 21, 2026 | Scimeca DarioGeneral Counsel and Secretary · O | ▼ Sale | 8,854 | $4.03 | $36K | -16.5% | plan |
| Jan 21, 2026 | Kelly John AlexanderChief Financial Officer · O | ▼ Sale | 15,213 | $4.03 | $61K | -12.5% | plan |
| Jan 21, 2026 | SMITH J. JEFFERSONChief Research Officer · O | ▼ Sale | 10,200 | $4.03 | $41K | -8.5% | plan |
| Dec 16, 2025 | Germano Geno JD | ▲ Buy | 3,000 | $4.72 | $14K | +14.4% | — |
| Dec 16, 2025 | Frankel StanleyD | ▲ Buy | 2,700 | $4.7 | $13K | +16.1% | — |
| Dec 15, 2025 | Brown MelindaD | ▲ Buy | 1,381 | $4.97 | $7K | +6.3% | — |
| Nov 3, 2025 | Kelly John AlexanderChief Financial Officer · O | ▼ Sale | 1,303 | $6.49 | $8K | -1.7% | plan |
| Nov 3, 2025 | Scimeca DarioGeneral Counsel and Secretary · O | ▼ Sale | 665 | $6.49 | $4K | -2.3% | plan |
| Nov 3, 2025 | Amoroso MichaelPresident and CEO · O·D | ▼ Sale | 3,409 | $6.49 | $22K | -2.9% | plan |
| Sep 26, 2025 | Frankel StanleyD | ▲ Buy | 2,700 | $4.97 | $13K | +19.2% | — |
| Sep 22, 2025 | Brown MelindaD | ▲ Buy | 1,400 | $4.89 | $7K | +6.8% | — |
Every $DTIL filing on this page is one API call away
The same Form 4 data over REST or MCP, already grouped into events with the plan flag and the dollar value read. A free key does 100 calls a day and needs no card. Prefer email? Precision Biosciences filings can reach your inbox instead.
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. This page shows open-market activity: purchases (code P), sales (S) and dispositions back to the issuer (D). Scheduled compensation events such as stock grants and option exercises are also filed on Form 4 but carry no trading signal, so they are not shown and counts here can be lower than the raw EDGAR filing total. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $DTIL feed.